Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 15Genitourinary 9Head & Neck 5Gastrointestinal 5Thoracic 4Other 4Lymphoid 4Plasma cell 3Gynecologic 3Dermatologic 3Other hematologic neoplasm 2Tumor-Agnostic 1Other solid neoplasm 1Other neoplasm 1Myeloid 1CNS 1

Conditions

Advanced Cancers 1

Interventions

Cisplatin 60Carboplatin 55Cyclophosphamide 47Pemetrexed 45Irinotecan 33pembrolizumab 32Paclitaxel 29Etoposide 29Gemcitabine 28Nivolumab 24Bevacizumab 24Interviews as Topic 23Vincristine 22Capecitabine 22Topotecan 20Filgrastim 20Early Intervention, Educational 20fludarabine 19Oxaliplatin 19Docetaxel 19Specimen Handling 18Drug Therapy 18Temozolomide 17Sorafenib 17Leucovorin 17Everolimus 17Educational Status 17Radiotherapy 16Methods 16Fluorouracil 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Sugars × Other solid neoplasm × Clear all
NCT01375114 2026-05-04

The Effects of Ginseng on Cancer-Related Fatigue

M.D. Anderson Cancer Center

Phase 1/2 Active not recruiting
165 enrolled 14 charts
Other solid neoplasm

Advanced Cancers

Data powered by HemOnc (CC BY 4.0) Colophon âš¡